Protagonist Therapeutics, Inc.【PTGX】 純利益の推移
機能の使い方
|
（単位：千ドル）
|
純利益
|
前年比（％）
|
|
4Q25
|
-44,384
|
-133.7%
|
|
3Q25
|
-39,339
|
+18.5%
|
|
2Q25
|
-34,771
|
+13.6%
|
|
1Q25
|
-11,655
|
-105.6%
|
|
4Q24
|
131,674
|
+381.7%
|
|
3Q24
|
-33,210
|
-2.6%
|
|
2Q24
|
-30,616
|
-20.4%
|
|
1Q24
|
207,340
|
-714.8%
|
|
4Q23
|
27,335
|
-179.9%
|
|
3Q23
|
-34,105
|
+9.2%
|
|
2Q23
|
-38,460
|
-6.3%
|
|
1Q23
|
-33,725
|
+61.1%
|
|
4Q22
|
-34,194
|
-7.4%
|
|
3Q22
|
-31,232
|
-7.6%
|
|
2Q22
|
-41,037
|
+33.1%
|
|
1Q22
|
-20,930
|
-12.8%
|
|
4Q21
|
-36,907
|
+95.4%
|
|
3Q21
|
-33,804
|
+335.5%
|
|
2Q21
|
-30,842
|
+58.8%
|
|
1Q21
|
-23,998
|
+19.5%
|
|
4Q20
|
-18,886
|
+7.9%
|
|
3Q20
|
-7,763
|
-52.7%
|
|
2Q20
|
-19,421
|
-33.4%
|
|
1Q20
|
-20,080
|
+42.4%
|
|
4Q19
|
-17,501
|
+26.2%
|
|
3Q19
|
-16,409
|
+87.9%
|
|
2Q19
|
-29,174
|
+236.8%
|
|
1Q19
|
-14,103
|
+84.1%
|
|
4Q18
|
-13,865
|
+354.3%
|
|
3Q18
|
-8,735
|
+81.0%
|
|
2Q18
|
-8,663
|
-42.2%
|
|
1Q18
|
-7,661
|
-45.7%
|
|
4Q17
|
-3,052
|
-72.9%
|
|
3Q17
|
-4,825
|
-31.9%
|
|
2Q17
|
-14,979
|
+111.0%
|
|
1Q17
|
-14,101
|
-
|
|
4Q16
|
-11,248
|
-
|
|
3Q16
|
-7,084
|
-
|
|
2Q16
|
-7,098
|
-
|